{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:37:25Z","timestamp":1790739445995,"version":"4.1.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,8]]},"DOI":"10.18632\/oncotarget.18656","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T16:47:54Z","timestamp":1498582074000},"page":"63096-63109","source":"Crossref","is-referenced-by-count":9,"title":["Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Blake A.","family":"Jacobson","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad A.","family":"Sadiq","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaogeng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Jay-Dixon","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Drees","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent S.","family":"Sorenson","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA"},{"name":"Division of Hematology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kratzke","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN, USA"},{"name":"Department of Surgery, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3816\/CLC.2009.n.014","article-title":"Malignant pleural mesothelioma: medical treatment update","volume":"10","author":"Mafafo","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14712598.2013.749851","article-title":"Oncolytic measles virus strains as novel anticancer agents","volume":"13","author":"Galanis","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/cgt.2010.10","article-title":"Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy","volume":"17","author":"Russell","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"4","first-page":"31","article-title":"Measles virus and CD46","volume":"329","author":"Atkinson","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"5","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Peng","year":"2004","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","article-title":"Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer","volume":"69","author":"Nakamura","year":"2009","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1517\/14712590903170653","article-title":"Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways","volume":"9","author":"Russell","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/0008-5472.CAN-14-2789","article-title":"Targeting the eIF4F translation initiation complex: a critical nexus for cancer development","volume":"75","author":"Sonenberg","year":"2015","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/cgt.2015.34","article-title":"Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells","volume":"22","author":"Kratzke","year":"2015","journal-title":"Cancer Gene Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.bjc.6605184","article-title":"Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma","volume":"101","author":"Kratzke","year":"2009","journal-title":"Br J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrmicro2655","article-title":"Viral subversion of the host protein synthesis machinery","volume":"9","author":"Mohr","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"12","first-page":"979","article-title":"Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma","volume":"134","author":"Harris","year":"1989","journal-title":"Am J Pathol"},{"key":"13","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Richardson","year":"2011","journal-title":"PLoS Pathog"},{"key":"14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Cichutek","year":"2011","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"e81669","DOI":"10.1371\/journal.pone.0081669","article-title":"Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide","volume":"8","author":"Kratzke","year":"2013","journal-title":"PLoS One"},{"key":"16","first-page":"2462","article-title":"Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme","volume":"63","author":"Galanis","year":"2003","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.18632\/oncotarget.598","article-title":"Tumor suppression by small molecule inhibitors of translation initiation","volume":"3","author":"Wagner","year":"2012","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1016\/S0021-9258(17)39529-7","article-title":"Immunological detection of the messenger RNA cap-binding protein","volume":"260","author":"Rhoads","year":"1985","journal-title":"J Biol Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0021-9258(19)75938-9","article-title":"Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F","volume":"262","author":"Hershey","year":"1987","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/345544a0","article-title":"Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap","volume":"345","author":"Sonenberg","year":"1990","journal-title":"Nature"},{"key":"22","doi-asserted-by":"publisher","first-page":"44892","DOI":"10.18632\/oncotarget.6285","article-title":"Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response","volume":"6","author":"Gregoire","year":"2015","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/ijo.2013.1914","article-title":"Primary resistance phenomena to oncolytic measles vaccine viruses","volume":"43","author":"Lauer","year":"2013","journal-title":"Int J Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Lauer","year":"2013","journal-title":"J Virol"},{"key":"25","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/0008-5472.CAN-07-6265","article-title":"Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response","volume":"68","author":"Gregoire","year":"2008","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2249.1998.00581.x","article-title":"Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance","volume":"113","author":"Mark-Bentankur","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"27","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1128\/JVI.00570-07","article-title":"Measles virus N protein inhibits host translation by binding to eIF3-p40","volume":"81","author":"Kai","year":"2007","journal-title":"J Virol"},{"key":"28","first-page":"1659","article-title":"More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer","volume":"74","author":"Romao","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO;2-9","article-title":"Complement-regulatory proteins in ovarian malignancies","volume":"70","author":"Meri","year":"1997","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-14-2533","article-title":"Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer","volume":"75","author":"Federspiel","year":"2015","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nm0502-527","article-title":"Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides","volume":"8","author":"Russell","year":"2002","journal-title":"Nat Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-1-61779-095-9_14","article-title":"Manufacture of measles viruses","volume":"737","author":"Federspiel","year":"2011","journal-title":"Methods Mol Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2004.05.024","article-title":"Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells","volume":"5","author":"Polunovsky","year":"2004","journal-title":"Cancer Cell"},{"key":"34","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1172\/JCI32044","article-title":"Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity","volume":"117","author":"Sissons","year":"2007","journal-title":"J Clin Invest"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T02:30:38Z","timestamp":1659148238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":34,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,8]]}},"alternative-id":["18656","28968974"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18656","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]}}}